PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
26-Aug-2025 PannTheraPi prepares plans to conduct its first Phase IIa clinical trial with PTI5803 in patients with resistant epilepsy and accelerate the development of its proprietary pipeline PannTheraPi
26-Aug-2025 Meteor Biotech installs spatial biology platform, CosmoSort, at Magnify, CNSI incubator on UCLA campus Andrew Lloyd Associates
26-Aug-2025 Roca Therapeutics secures first-ever EMA recognition of Radiation Maculopathy as distinct indication – and Orphan Drug Designation Andrew Lloyd Associates
26-Aug-2025 Akiram: Clinical Phase I clinical trial with AKIR001 progresses to next step following completion of first cohort Akiram
21-Aug-2025 Healthcare Analytics Market to Reach USD 217.2 Billion by 2032, Growing at 23.4% CAGR | Global Outlook and Growth Insights Ameco Research
21-Aug-2025 Healthcare Consulting Services Market to More Than Double to USD 59.2 Billion by 2032 | 8.7% CAGR Signals Strategic Boom Ameco Research
19-Aug-2025 Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC Everest Medicines Limited
15-Aug-2025 Bionova Scientific opens new pDNA facility in Texas to support rapidly growing biopharma industry fr financial relations GmbH
14-Aug-2025 Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Sanofi
12-Aug-2025 PureTech Announces the Launch of Celea Therapeutics with a Mission to Transform the Treatment of Respiratory Diseases Celea Therapeutics
12-Aug-2025 FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response FoRx Therapeutics
12-Aug-2025 Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS) Newron
12-Aug-2025 Lilly and UK Government announce obesity pathway innovation programme for up to £85 million Lilly
12-Aug-2025 Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Concept Mabylon AG
11-Aug-2025 CapeStart Expands Operations with New Office in Chennai to Support AI Center of Excellence CapeStart
11-Aug-2025 CapeStart Expands Operations with New Office in Chennai to Support AI Center of Excellence CapeStart
08-Aug-2025 UK scientists create groundbreaking NHS pneumonia test to tackle hospital acquired infections EDX Medical
08-Aug-2025 Global Long Term Care Market to Surpass USD 2.03 Trillion by 2033, Driven by Aging Population and Rising Chronic Illnesses Ameco Research
07-Aug-2025 ASP Introduces BIOTRACE™ Instant Read Steam System, Delivering Sterility Assurance in Just Seven Seconds Advanced Sterilization Products
07-Aug-2025 Altimetrik recognised as Major Contender in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment 2025 Altimetrik